Google
 
Google

World Stem Cell Summit 2010

Friday, September 26, 2008

Nature Clinical Practice Oncology - Table of Contents alert Volume 5 Issue 10

NATURE CLINICAL PRACTICE ONCOLOGY

October 2008 Volume 5 Number 10

Visit Nature Clinical Practice Oncology online to browse the journal.

Now available at http://ealerts.nature.com/cgi-bin24/DM/y/enkY0Xztnp0HjM0UgF0EI

=====================================================================

Announcing the NEW British Journal of Cancer website with enhanced
functionality

Visit http://ealerts.nature.com/cgi-bin24/DM/y/enkY0Xztnp0HjM0f8c0EH
and benefit from new features, including RSS Web Feeds, Article Links
and Top Ten downloaded articles.

=====================================================================

----------------------
EDITORIAL
----------------------
Radiation oncology health technology assessment-the best is the enemy
of the good
Soren M Bentzen
http://ealerts.nature.com/cgi-bin24/DM/y/enkY0Xztnp0HjM0B6F80E5

----------------------
RESEARCH HIGHLIGHTS
----------------------
Nonmyeloablative stem-cell transplantation can induce long-term remission
in relapsed FL
http://ealerts.nature.com/cgi-bin24/DM/y/enkY0Xztnp0HjM0B6GA0EG

Salvage radiotherapy improves survival in men with recurrence after
radical prostatectomy
http://ealerts.nature.com/cgi-bin24/DM/y/enkY0Xztnp0HjM0B6GB0EH

Chromosomal instability confers poor prognosis in patients with colorectal
cancer
http://ealerts.nature.com/cgi-bin24/DM/y/enkY0Xztnp0HjM0B6GC0EI

Small molecule JAK2 inhibitor is effective in murine model of polycythemia
vera
http://ealerts.nature.com/cgi-bin24/DM/y/enkY0Xztnp0HjM0B6GD0EJ

High-dose conformal RT improves tumor control in patients with prostate
cancer
http://ealerts.nature.com/cgi-bin24/DM/y/enkY0Xztnp0HjM0B6GE0EK

Preoperative chemoradiation in addition to preoperative chemotherapy
in stage III NSCLC
http://ealerts.nature.com/cgi-bin24/DM/y/enkY0Xztnp0HjM0B6GF0EL

Vitamin D concentration does not affect the risk of prostate cancer
http://ealerts.nature.com/cgi-bin24/DM/y/enkY0Xztnp0HjM0B6GG0EM

Liver resection with salvage transplantation for hepatocellular carcinoma
http://ealerts.nature.com/cgi-bin24/DM/y/enkY0Xztnp0HjM0B6GH0EN

----------------------
PRACTICE POINTS
----------------------
The ROC 'n' role of the multiplex assay for early detection of ovarian
cancer
Alpa M Nick and Anil K Sood
http://ealerts.nature.com/cgi-bin24/DM/y/enkY0Xztnp0HjM0B6GI0EO

Choosing a taxane for adjuvant treatment of breast cancer: more than a
flip of the coin?
Linda Vahdat
http://ealerts.nature.com/cgi-bin24/DM/y/enkY0Xztnp0HjM0B6GJ0EP

Should surgery followed by whole-brain radiation therapy be the standard
treatment for single brain metastasis?
David W Andrews
http://ealerts.nature.com/cgi-bin24/DM/y/enkY0Xztnp0HjM0B6GK0EQ

----------------------
VIEWPOINT
----------------------
Intermittent androgen blockade should be regarded as standard therapy
in prostate cancer
Bostjan Seruga and Ian F Tannock
http://ealerts.nature.com/cgi-bin24/DM/y/enkY0Xztnp0HjM0B6GL0ER

----------------------
REVIEWS
----------------------
Gene-expression profiling in epithelial ovarian cancer
Panagiotis A Konstantinopoulos, Dimitrios Spentzos and Stephen A Cannistra
http://ealerts.nature.com/cgi-bin24/DM/y/enkY0Xztnp0HjM0B6GM0ES

Strategies for discovering novel cancer biomarkers through utilization
of emerging technologies
Vathany Kulasingam and Eleftherios P Diamandis
http://ealerts.nature.com/cgi-bin24/DM/y/enkY0Xztnp0HjM0B6GN0ET

Mechanisms of Disease: survival benefit of temsirolimus validates a role
for mTOR in the management of advanced RCC
Robert A Figlin
http://ealerts.nature.com/cgi-bin24/DM/y/enkY0Xztnp0HjM0B6GO0EU

Mechanisms of Disease: signal transduction in lung carcinogenesis-a
comparison of smokers and never-smokers
Giannis Mountzios, Pierre Fouret and Jean-Charles Soria
http://ealerts.nature.com/cgi-bin24/DM/y/enkY0Xztnp0HjM0B6GP0EV

----------------------
CASE STUDY
----------------------
The impact of histopathologic diagnosis on the proper management of
testis neoplasms
Giovanni Ponti, Maurilio Ponzoni, Andres JM Ferreri, Marco Foppoli,
Luca Mazzucchelli and Emanuele Zucca
http://ealerts.nature.com/cgi-bin24/DM/y/enkY0Xztnp0HjM0B6GQ0EW

=====================================================================

Leukemia - Celebrating 20 years of distinguished research

Leukemia covers all aspects of research and treatment of leukemia and
allied diseases. It brings the science community the latest advances
in Oncogenes, Growth factors, Stem cells, Leukemia genomics, Cell
cycle, Signal transduction, and Molecular targets for therapy.

Visit http://ealerts.nature.com/cgi-bin24/DM/y/enkY0Xztnp0HjM0U6k0E5
for a variety of free featured articles and special promotions throughout
the year.

=====================================================================

You have been sent this Table of Contents Alert because you have opted
in to receive it. You can change or discontinue your e-mail alerts at
any time, by modifying your preferences on your nature.com account at:
http://ealerts.nature.com/cgi-bin24/DM/y/enkY0Xztnp0HjM0Zzu0ET
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department:
registration@nature.com

For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com

For other enquiries, please contact our customer feedback department:
feedback@nature.com

Nature Publishing Group | 75 Varick Street, 9th Floor | New York |
NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston

=====================================================================

Google

Any Comments ?.......

E-mail: manojhind2001us@gmail.com
Google
 

World Time